Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials.
Wooltorton
Eric
E
D016907:Adverse Drug Reaction Reporting Systems; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy / Q000523:psychology; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D002561:Cerebrovascular Disorders / Q000139:chemically induced*; D002986:Clinical Trials as Topic; D000075202:Contraindications; D006801:Humans; D000077152:Olanzapine; D011358:Product Surveillance, Postmarketing
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine